Cystic Fibrosis Clinical Trials in Charleston, South Carolina
6 studies are recruiting for cystic fibrosis in Charleston, South Carolina right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Impact of Sinus Surgery on Individuals With Cystic Fibrosis
This study will be a prospective, observational study of patients who undergo endoscopic sinus surgery for cystic fibrosis-related chronic rhinosinusitis (CRS). Individuals who do not undergo surgery but are treated medically for CRS will also be enrolled to serve as a control group. Outcomes analy…
- Stage
- Not phased
- Ages
- 18 to 99
- Site
- Medical University of South Carolina, Charleston, South Carolina
- Locations
- 9 in total
- Run by
- University of California, Los Angeles
-
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
The STOP PEDS RCT is a multicenter, parallel, open label randomized controlled trial evaluating the long-term (one year) and short-term safety and efficacy of two antibiotic treatment strategies for the management of outpatient pulmonary exacerbations (PEx) in the pediatric CF population.
- Stage
- Not phased
- Ages
- 3 to 18
- Site
- Medical University of South Carolina, Charleston, South Carolina
- Locations
- 33 in total
- Run by
- University of Washington, the Collaborative Health Studies Coordinating Center
-
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
The purpose of this study is to look at pulmonary exacerbations in people with cystic fibrosis (CF) that need to be treated with antibiotics given through a tube inserted into a vein (intravenous or IV). A pulmonary exacerbation is a worsening of respiratory symptoms in people with CF that needs me…
- Stage
- Phase 4
- Ages
- 6 and older
- Site
- Medical University of South Carolina, Charleston, South Carolina
- Locations
- 60 in total
- Run by
- Chris Goss
-
Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
ARCT-032-02 is a Phase 2, open-label, multicenter, multiple-ascending dose study of ARCT-032 in adults with CF who are not eligible for CFTR modulator therapy or are not taking CFTR modulators due to drug intolerance, poor response, or lack of access to modulators.
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Medical University of South Carolina, Charleston, South Carolina
- Locations
- 13 in total
- Run by
- Arcturus Therapeutics, Inc.
-
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
The goal of this observational prospective study is to determine the health impact of parenthood on United States (US) people with CF in the era of CF transmembrane regulator protein (CFTR) modulators. The investigators will collect physical and mental health data to comprehensively evaluate the im…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Medical University of South Carolina, Charleston, South Carolina
- Locations
- 18 in total
- Run by
- University of Pittsburgh
-
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
The REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators. The goal of the REACH study is to collect research data, including health data and specimens, from people with CF who do not take CFTR modulators. This data may be used to in…
- Stage
- Not phased
- Ages
- 12 and older
- Site
- Medical University of South Carolina, Charleston, South Carolina
- Locations
- 68 in total
- Run by
- Nicole Hamblett
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.